Evidence map›Paper›PMID 42780215›Full record

ArticlebioRxiv : the preprint server for biology2026

PRDM9-mediated meiotic hotspot specification is constrained in humans despite extensive sequence diversity.

Rachel L Cosby, Marja Brolinson King, Alexandra M Poch, M Blake Evans, Dawn E Watkins-Chow, Briana Young, Sherry Ralls, Veronica Gomez-Lobo, Kenneth I Aston, Donald F Conrad and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel L CosbyThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2696-5575
Marja Brolinson KingThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8815-3364
Alexandra M PochThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-4815-970X
M Blake EvansThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-4144-7891
Dawn E Watkins-ChowThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-4355-0868
Briana YoungThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-7417-3540
Sherry RallsThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0009-0000-0866-5670
Veronica Gomez-LoboThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-9396-2142
Kenneth I AstonAndrology Laboratory, Department of Surgery (Urology), University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0001-6459-2103
Donald F ConradCenter for Embryonic Cell & Gene Therapy, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-3828-8970
Todd S MacfarlanThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2495-9809

Funding

Mechanisms of Mammalian Epigenome ReprogrammingZIAHD008933 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MACFARLAN, TODD SCOTT · 2013 to 2025
$19.1M
Project IIIP50HD096723 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI John C Schimenti · 2019 to 2026
$15.0M
GENOMICS OF SPERMATOGENIC IMPAIRMENTR01HD078641 · NICHD · WASHINGTON UNIVERSITY · PI Kenneth Ivan Aston, DONALD F. CONRAD · 2014 to 2026
$6.3M
Rare conditions in PAG-which will involve 4 other protocols ZIAHD009006 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI GOMEZ-LOBO, VERONICA · 2022 to 2025
$2.4M
Intramural NIH HHS ZIA HD008933Intramural NIH HHS ZIA HD009006NICHD NIH HHS P50 HD096723NICHD NIH HHS R01 HD078641
6 · The paper itself

Abstract

PRDM9 specifies meiotic recombination hotspots through a rapidly evolving C2H2 zinc-finger (ZNF) coding minisatellite that determines DNA-binding specificity. Although this minisatellite harbors extraordinary allelic diversity in humans, the functional consequences of most naturally occurring variants remain unknown. Here we functionally characterize 80 human PRDM9 alleles using genome-wide chromatin profiling. Despite extensive sequence diversity within the ZNF array, most alleles function indistinguishably from common A and C hotspot-specifying alleles, revealing that human PRDM9 function is more constrained than its sequence variation predicts. In contrast, rare variants identified in infertile individuals occupy two functional extremes: abundant and novel DNA binding specificity or minimal DNA binding, suggesting that both gain- and loss-of-function alleles may disrupt symmetric hotspot specification during meiosis, plausibly contributing to human infertility. Together, our findings define the functional landscape of human PRDM9 variation and provide a framework for interpreting the impact of newly discovered PRDM9 alleles.

Identifiers

PMID42780215
PMCPMC13596578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.